Your browser doesn't support javascript.
loading
Call for action: expanding global access to hereditary cancer genetic testing.
Bychkovsky, Brittany; Rana, Huma Q; Ademuyiwa, Foluso; Plichta, Jennifer; Anderson, Karen; Nogueira-Rodrigues, Angélica; Santa-Maria, Cesar A; Coffman, Lan G; Marquez, Carol; Das, Arunangshu; Taghian, Alphonse; Koeller, Diane R; Sandoval, Renata L; Park, Ben Ho; Dizon, Don S.
Afiliación
  • Bychkovsky B; Global Cancer Institute, Boston, MA 02114, USA; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: brittany_bychkovsky@dfc
  • Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Ademuyiwa F; Global Cancer Institute, Boston, MA 02114, USA; Division of Oncology, Washington University School of Medicine, St Louis, MO, USA.
  • Plichta J; Global Cancer Institute, Boston, MA 02114, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Anderson K; Global Cancer Institute, Boston, MA 02114, USA; Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
  • Nogueira-Rodrigues A; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Santa-Maria CA; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Coffman LG; Global Cancer Institute, Boston, MA 02114, USA; Magee-Womens Research Institute, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Marquez C; Global Cancer Institute, Boston, MA 02114, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Das A; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Square Hospitals, Dhaka, Bangladesh.
  • Taghian A; Global Cancer Institute, Boston, MA 02114, USA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sandoval RL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Oncology, Syrian-Lebanese Hospital, Brasília, Brazil.
  • Park BH; Global Cancer Institute, Boston, MA 02114, USA; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Dizon DS; Global Cancer Institute, Boston, MA 02114, USA; Lifespan Cancer Institute and Brown University, Providence, RI, USA.
Lancet Oncol ; 23(9): 1124-1126, 2022 09.
Article en En | MEDLINE | ID: mdl-36055301
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article